Salmonics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Corporate
- Financing Rounds
-
2
- Investments
-
1
Salmonics General Information
Description
Manufacturer of fish-derived plasma proteins and reagents intended for research and development worldwide. The company specializes in developing proteins and reagents from salmon and trout blood to offer sustainable alternatives to traditional products, thereby primarily serving the scientific community and providing products for usage in regenerative medicine, pain studies and other research fields.
Contact Information
Website
www.salmonics.coCorporate Office
- TechPlace, 74 Orion Street
- Brunswick, ME 04011
- United States
Corporate Office
- TechPlace, 74 Orion Street
- Brunswick, ME 04011
- United States
Salmonics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Salmonics Comparisons
Industry
Financing
Details
Salmonics Competitors (24)
One of Salmonics’s 24 competitors is Sino Biological, a Formerly VC-backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sino Biological | Formerly VC-backed | Beijing, China | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | ||||
| Halozyme Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| MediGene | Formerly VC-backed | Planegg, Germany | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH |
Salmonics Patents
Salmonics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230123857-A1 | Process of using a fish plasma component in a nutrient medium for cell culture | Inactive | 01-Sep-2021 | ||
| US-20230235281-A2 | Process of using a fish plasma component in a nutrient medium for cell culture | Inactive | 01-Sep-2021 | ||
| US-20210290123-A1 | Device and method of obtaining aseptic blood from fish | Inactive | 20-Mar-2020 | ||
| US-20120009175-A1 | Method of using salmon thrombin to alleviate pain | Active | 15-Oct-2010 | ||
| US-8771684-B2 | Method of using salmon thrombin to alleviate pain | Active | 15-Oct-2010 | A61K38/4833 |
Salmonics Signals
Salmonics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Salmonics Acquisitions (1)
Salmonics’s most recent deal was a Merger/Acquisition with Sea Run Holdings. The deal was made on 01-Jan-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sea Run Holdings | 01-Jan-2021 | Merger/Acquisition | Discovery Tools (Healthcare) |
Salmonics FAQs
-
When was Salmonics founded?
Salmonics was founded in 2020.
-
Where is Salmonics headquartered?
Salmonics is headquartered in Brunswick, ME.
-
What is the size of Salmonics?
Salmonics has 9 total employees.
-
What industry is Salmonics in?
Salmonics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Salmonics a private or public company?
Salmonics is a Private company.
-
What is Salmonics’s current revenue?
The current revenue for Salmonics is .
-
How much funding has Salmonics raised over time?
Salmonics has raised $315K.
-
Who are Salmonics’s investors?
Leroy Seafood Group has invested in Salmonics.
-
Who are Salmonics’s competitors?
Sino Biological, Cytovance Biologics, Halozyme Therapeutics, MediGene, and Adimab are some of the 24 competitors of Salmonics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process